Helen Liu
InvestorSenior Associate, CCD at Abingworth
About
Helen Liu joined Abingworth in April 2025 and works with the firm's transatlantic investment team, focusing on Clinical Co-Development, evaluating new opportunities and supporting existing investments. She previously was a Senior Associate at Sagard Healthcare investing in biopharmaceuticals, diagnostics, and medical devices via royalty monetization and private credit, and earlier held roles at Canada Pension Plan Investment Board and MaRS Innovation. She holds an Honors B.Sc. in Life Science and a Masters of Health Science from the University of Toronto and is a CFA charterholder.
Invests in
BiotechMedical Devices
Colleagues at Abingworth
Alex Asquith
Counsel at Abingworth
Andrew Sinclair
Managing Director, Head of Publics & Late Stage at Abingworth
Ankur Shah
Vice President, CCD at Abingworth
Anna Slezak
Senior Associate at Abingworth
Bali Muralidhar
Global Head of Life Sciences & CIO at Abingworth
Carlos Paya
Venture Partner at Abingworth
Dayle Hogg
Operating Executive at Abingworth
Diya Malhotra
Principal at Abingworth